newsA new gene therapy developed by UC San Francisco has…
22 December 2022 | By Catherine Eckford (European Pharmaceutical Review)
A new gene therapy developed by UC San Francisco has enabled ten young Artemis-SCID patients to achieve full T-cell immunity.